Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

NCT03175029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Detrusor Underactivity
Overactive Bladder

Interventions

DRUG: TAC-302
DRUG: Placebo

Sponsor

Taiho Pharmaceutical Co., Ltd.